Dealroom Secures €5.8 Million to Accelerate US Expansion and AI Capabilities
Amsterdam, Saturday 31 January 2026
Led by Índico Capital Partners, this €5.8 million investment empowers the Amsterdam-based platform to scale its predictive intelligence across the US, moving beyond simple historical reporting.
Strategic Capital for Global Intelligence
On 28 January 2026, Dealroom confirmed the successful closure of its €5.8 million ($7 million) funding round, marking a significant milestone for the company founded in 2013 [1]. The investment was led by Lisbon-based Índico Capital Partners, with strategic participation from Rabobank and existing backers including Beringea, Shoe Investments, and Knight Capital [1]. This capital injection is specifically earmarked to bolster the firm’s presence in the United States and to deepen its investment in data assets and artificial intelligence capabilities [1]. By securing this funding, Dealroom aims to transition from standard historical reporting to offering predictive intelligence, a shift that Stephan de Moraes, Managing General Partner at Índico Capital Partners, identifies as the company’s unique competitive advantage in a market saturated with retrospective data [1].
Predictive Intelligence and Global Ambitions
The drive towards predictive analytics comes at a time when the global innovation economy demands real-time insights rather than lagging indicators. Yoram Wijngaarde, founder and CEO of Dealroom, emphasised that data on technology and innovation has never been more crucial, noting that the funding will allow the platform to expand how it maps the world’s tech ecosystems [1]. To support this global mandate, the company has already established a dedicated team and office in Lisbon, Portugal, complementing its Amsterdam headquarters [1]. The integration of AI-driven data with a robust network of partnerships is designed to provide investors with actionable insights, moving the industry forward by identifying high-growth potential in nascent sectors before they become mainstream [1].
Mapping the Surge in Healthtech and AI
The necessity for such granular, AI-driven mapping is evident when analysing complex, rapidly evolving sectors like healthtech. In the Netherlands alone, healthtech ventures raised over €800 million in 2025, driven by an ageing population and strong government support [2]. Dealroom’s enhanced capabilities are essential for tracking these intricate market dynamics, where trends for 2026 include AI-driven predictive diagnostics, digital therapeutics, and the digitalisation of legacy supply chains in healthcare [2]. With the sector expected to grow by between 25 and 40 per cent in 2026 due to AI integration, the ability to identify early-stage startups—which may seek pre-seed or seed rounds of €1 million to €5 million—becomes vital for venture capitalists [2].
Navigating Future Market Complexities
As legacy industries undergo digitalisation, the distinction between traditional sectors and the digital economy continues to blur. Active investors such as Inkef Capital, Prime Ventures, and international players like Index Ventures rely on accurate data to navigate risks, such as long regulatory timelines in biotech, against the potential for high exit multiples through acquisition [2]. Dealroom’s expanded footprint and improved AI product capabilities position it to serve as the critical infrastructure for these stakeholders, offering the robust and actionable insights required to capitalise on the next wave of technological innovation [1][2].